Romania Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Romania Pharmaceuticals and Healthcare Report

Romania Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Romania Pharmaceuticals and Healthcare Report
Published Sep 03, 2016
85 pages — Published Sep 03, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Government measures to reduce the cost of pharmaceuticals by promoting a consumption shift towards generic drugs and recentralising drug procurement The new method for calculating drug reimbursement is hindering sales of innovative drugs Problems in healthcare sector financing, particularly state hospital drug purchasing The costs of modernisation potentially derailing the recent rapid improvement of the domestic regulatory infrastructure Introduction of prescribing restrictions as a possibility Roll-out of co-payments to negatively impact volume sales of expensive medicines in favour of cheaper products Long term viability of healthcare system in question due to ageing population and falling birth rates ...

...� Business Monitor International Ltd Page - Pharmaceutical SWOT Analysis - Continued EU accession stimulating rapid regulatory reforms, dramatically improving the market environment for foreign companies. High growth potential in private healthcare sector. ...High growth potential in private healthcare sector. Pharmaceuticals growth led by the low cost generic and OTC drug sectors, given the increased health awareness and a desire to seek treatment outside the cash-strapped state sector. Long term uptake in patented drugs expected as disease burden shifts towards chronic and non-communicable diseases Sustained, robust economic growth will improve consumer picture for OTC and generic medicines ...Pharmaceuticals growth led by the low cost generic and OTC drug sectors, given the increased health awareness and a desire to seek treatment outside the cash-strapped state sector. Long term uptake in patented drugs expected as disease burden shifts towards chronic and non-communicable diseases Sustained, robust economic growth will improve consumer picture for OTC and generic medicines

...Local drug manufacturing industry now largely in private and foreign hands. Consolidation of the wholesale and retail environment, signalling maturing environment. ...Consolidation of the wholesale and retail environment, signalling maturing environment. More transparent wholesale and retail sectors providing easier entry and greater marketing potential for manufacturers. Fast-tracking registration available for urgently needed drugs. Comparatively high market share for patented products against neighbouring markets. Healthcare market reform, including the introduction of co-payments will increase access to higher value drugs, though as a proportion of total it is expected to drop.

...

  
Source:
Document ID
1748-2127
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Romania Pharmaceuticals and Healthcare Report" Sep 03, 2016. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Romania-Pharmaceuticals-and-Healthcare-Report-2026-297>
  
APA:
Business Monitor International - Industry Reports. (2016). Romania Pharmaceuticals and Healthcare Report Sep 03, 2016. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Romania-Pharmaceuticals-and-Healthcare-Report-2026-297>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.